{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:48:53Z","timestamp":1790725733508,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute hepatitis A caused by hepatitis A virus (HAV) infection is accompanied by severe liver injury in adult patients, and the liver injury is associated with the production of chemokines. Herein, we investigated the mechanism of how HAV infection induces the production of CXCR3 and CCR5 chemokines, such as CXCL10, CCL4 and CCL5. The production of CXCL10, CCL4 and CCL5 was markedly increased by HAV (HM-175\/18f) infection in the culture of primary human hepatocytes and HepG2 cells. In particular, CXCL10 was produced in HAV-infected cells, not in neighboring uninfected cells. Moreover, these chemokines were significantly increased in the sera of acute hepatitis A patients. The production of IFN-\u03bbs was also robustly induced by HAV infection, and the blocking of secreted IFN-\u03bbs partially abrogated the production of CCL4 and CCL5 in HAV-infected cells. However, CXCL10 production was not decreased by the blocking of IFN-\u03bbs. Instead, CXCL10 production was reduced by silencing the expression of RIG-I-like receptor (RLR) signal molecules, such as mitochondrial antiviral signaling protein and interferon regulatory factor 3, in HAV-infected cells. In conclusion, HAV infection strongly induces the production of helper 1 T cell-associated chemokines, particularly CXCL10 via RLR signaling, even without secreted IFNs.<\/jats:p>","DOI":"10.1038\/s41598-017-06784-x","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T10:14:17Z","timestamp":1500459257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["CXCL10 is produced in hepatitis A virus-infected cells in an IRF3-dependent but IFN-independent manner"],"prefix":"10.1038","volume":"7","author":[{"given":"Pil Soo","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Hui","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeewon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Kew","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6308-9503","authenticated-orcid":false,"given":"Eui-Cheol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,25]]},"reference":[{"key":"6784_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3350\/cmh.2014.20.2.162","volume":"20","author":"SJ Chung","year":"2014","unstructured":"Chung, S. J. et al. Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea. Clin Mol Hepatol \n                           20, 162\u2013167, doi:10.3350\/cmh.2014.20.2.162 (2014).","journal-title":"Clin Mol Hepatol"},{"key":"6784_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/hep.27537","volume":"61","author":"MG Collier","year":"2015","unstructured":"Collier, M. G., Tong, X. & Xu, F. Hepatitis A hospitalizations in the United States, 2002\u20132011. Hepatology \n                           61, 481\u2013485, doi:10.1002\/hep.27537 (2015).","journal-title":"Hepatology"},{"key":"6784_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nri.2016.69","volume":"16","author":"EC Shin","year":"2016","unstructured":"Shin, E. C., Sung, P. S. & Park, S. H. Immune responses and immunopathology in acute and chronic viral hepatitis. Nat Rev Immunol \n                           16, 509\u2013523, doi:10.1038\/nri.2016.69 (2016).","journal-title":"Nat Rev Immunol"},{"key":"6784_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coviro.2015.01.003","volume":"11C","author":"CM Walker","year":"2015","unstructured":"Walker, C. M., Feng, Z. & Lemon, S. M. Reassessing immune control of hepatitis A virus. Curr Opin Virol \n                           11C, 7\u201313, doi:10.1016\/j.coviro.2015.01.003 (2015).","journal-title":"Curr Opin Virol"},{"key":"6784_CR5","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1002\/hep.21052","volume":"43","author":"A Martin","year":"2006","unstructured":"Martin, A. & Lemon, S. M. Hepatitis A virus: from discovery to vaccines. Hepatology \n                           43, S164\u2013172, doi:10.1002\/hep.21052 (2006).","journal-title":"Hepatology"},{"key":"6784_CR6","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/med.21292","volume":"34","author":"Y Debing","year":"2014","unstructured":"Debing, Y., Neyts, J. & Thibaut, H. J. Molecular biology and inhibitors of hepatitis A virus. Med Res Rev \n                           34, 895\u2013917, doi:10.1002\/med.21292 (2014).","journal-title":"Med Res Rev"},{"key":"6784_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cytogfr.2014.07.003","volume":"25","author":"Q Feng","year":"2014","unstructured":"Feng, Q., Langereis, M. A. & van Kuppeveld, F. J. Induction and suppression of innate antiviral responses by picornaviruses. Cytokine Growth Factor Rev \n                           25, 577\u2013585, doi:10.1016\/j.cytogfr.2014.07.003 (2014).","journal-title":"Cytokine Growth Factor Rev"},{"key":"6784_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature04734","volume":"441","author":"H Kato","year":"2006","unstructured":"Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature \n                           441, 101\u2013105, doi:10.1038\/nature04734 (2006).","journal-title":"Nature"},{"key":"6784_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.12.010","volume":"40","author":"SH Park","year":"2014","unstructured":"Park, S. H. & Rehermann, B. Immune responses to HCV and other hepatitis viruses. Immunity \n                           40, 13\u201324, doi:10.1016\/j.immuni.2013.12.010 (2014).","journal-title":"Immunity"},{"key":"6784_CR10","doi-asserted-by":"publisher","first-page":"11223","DOI":"10.1073\/pnas.1101939108","volume":"108","author":"RE Lanford","year":"2011","unstructured":"Lanford, R. E. et al. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc Natl Acad Sci U S A \n                           108, 11223\u201311228, doi:10.1073\/pnas.1101939108 (2011).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6784_CR11","doi-asserted-by":"publisher","first-page":"e1002169","DOI":"10.1371\/journal.ppat.1002169","volume":"7","author":"L Qu","year":"2011","unstructured":"Qu, L. et al. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog \n                           7, e1002169, doi:10.1371\/journal.ppat.1002169 (2011).","journal-title":"PLoS Pathog"},{"key":"6784_CR12","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.1073\/pnas.0611506104","volume":"104","author":"Y Yang","year":"2007","unstructured":"Yang, Y. et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci USA \n                           104, 7253\u20137258, doi:10.1073\/pnas.0611506104 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"6784_CR13","doi-asserted-by":"publisher","first-page":"10968","DOI":"10.1128\/JVI.79.17.10968-10977.2005","volume":"79","author":"V Fensterl","year":"2005","unstructured":"Fensterl, V. et al. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon. J Virol \n                           79, 10968\u201310977, doi:10.1128\/JVI.79.17.10968-10977.2005 (2005).","journal-title":"J Virol"},{"key":"6784_CR14","doi-asserted-by":"publisher","first-page":"10252","DOI":"10.1128\/JVI.00869-14","volume":"88","author":"D Wang","year":"2014","unstructured":"Wang, D. et al. Hepatitis A virus 3C protease cleaves NEMO to impair induction of beta interferon. J Virol \n                           88, 10252\u201310258, doi:10.1128\/JVI.00869-14 (2014).","journal-title":"J Virol"},{"key":"6784_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI77527","volume":"125","author":"Z Feng","year":"2015","unstructured":"Feng, Z. et al. Human pDCs preferentially sense enveloped hepatitis A virions. J Clin Invest \n                           125, 169\u2013176, doi:10.1172\/JCI77527 (2015).","journal-title":"J Clin Invest"},{"key":"6784_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/mpat.1993.1001","volume":"14","author":"G Siegl","year":"1993","unstructured":"Siegl, G. & Weitz, M. Pathogenesis of hepatitis A: persistent viral infection as basis of an acute disease? Microb Pathog \n                           14, 1\u20138, doi:10.1006\/mpat.1993.1001 (1993).","journal-title":"Microb Pathog"},{"key":"6784_CR17","doi-asserted-by":"publisher","unstructured":"Koff, R. S. Hepatitis A. Lancet \n                           351, 1643\u20131649, doi:10.1016\/S0140-6736(98)01304-X (1998).","DOI":"10.1016\/S0140-6736(98)01304-X"},{"key":"6784_CR18","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1136\/gutjnl-2013-306213","volume":"64","author":"YS Choi","year":"2015","unstructured":"Choi, Y. S. et al. Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis. Gut \n                           64, 1303\u20131313, doi:10.1136\/gutjnl-2013-306213 (2015).","journal-title":"Gut"},{"key":"6784_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2016.22.1.1","volume":"22","author":"R Moreau","year":"2016","unstructured":"Moreau, R. Acute-on-chronic liver failure: a new syndrome in cirrhosis. Clin Mol Hepatol \n                           22, 1\u20136, doi:10.3350\/cmh.2016.22.1.1 (2016).","journal-title":"Clin Mol Hepatol"},{"key":"6784_CR20","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/hep.26901","volume":"59","author":"D Duffy","year":"2014","unstructured":"Duffy, D. et al. The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis. Hepatology \n                           59, 1273\u20131282, doi:10.1002\/hep.26901 (2014).","journal-title":"Hepatology"},{"key":"6784_CR21","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3349\/ymj.2016.57.3.652","volume":"57","author":"SY Shin","year":"2016","unstructured":"Shin, S. Y. et al. Comparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B. Yonsei Med J \n                           57, 652\u2013657, doi:10.3349\/ymj.2016.57.3.652 (2016).","journal-title":"Yonsei Med J"},{"key":"6784_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1084\/jem.20091959","volume":"207","author":"KM Kelly-Scumpia","year":"2010","unstructured":"Kelly-Scumpia, K. M. et al. Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. J Exp Med \n                           207, 319\u2013326, doi:10.1084\/jem.20091959 (2010).","journal-title":"J Exp Med"},{"key":"6784_CR23","doi-asserted-by":"publisher","unstructured":"Shin, E. C. et al. Delayed induction, not impaired recruitment, of specific CD8(+) T cells causes the late onset of acute hepatitis C. Gastroenterology \n                           141, 686\u2013695, 695 e681, 10.1053\/j.gastro.2011.05.006 (2011).","DOI":"10.1053\/j.gastro.2011.05.006"},{"key":"6784_CR24","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.4049\/jimmunol.177.8.5623","volume":"177","author":"H Weighardt","year":"2006","unstructured":"Weighardt, H. et al. Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J Immunol \n                           177, 5623\u20135630 (2006).","journal-title":"J Immunol"},{"key":"6784_CR25","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1084\/jem.20101664","volume":"207","author":"G Trinchieri","year":"2010","unstructured":"Trinchieri, G. Type I interferon: friend or foe? J Exp Med \n                           207, 2053\u20132063, doi:10.1084\/jem.20101664 (2010).","journal-title":"J Exp Med"},{"key":"6784_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3349\/ymj.2011.52.6.871","volume":"52","author":"W Kang","year":"2011","unstructured":"Kang, W. & Shin, E. C. Clinical implications of chemokines in acute and chronic hepatitis C virus infection. Yonsei Med J \n                           52, 871\u2013878, doi:10.3349\/ymj.2011.52.6.871 (2011).","journal-title":"Yonsei Med J"},{"key":"6784_CR27","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/hep.25897","volume":"56","author":"H Park","year":"2012","unstructured":"Park, H. et al. IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection. Hepatology \n                           56, 2060\u20132070, doi:10.1002\/hep.25897 (2012).","journal-title":"Hepatology"},{"key":"6784_CR28","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.1073\/pnas.1513341112","volume":"112","author":"PS Sung","year":"2015","unstructured":"Sung, P. S. et al. Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness. Proc Natl Acad Sci USA \n                           112, 10443\u201310448, doi:10.1073\/pnas.1513341112 (2015).","journal-title":"Proc Natl Acad Sci USA"},{"key":"6784_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0092-8674(95)90076-4","volume":"81","author":"JA Symons","year":"1995","unstructured":"Symons, J. A., Alcami, A. & Smith, G. L. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell \n                           81, 551\u2013560 (1995).","journal-title":"Cell"},{"key":"6784_CR30","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1128\/JVI.02007-13","volume":"88","author":"J Brownell","year":"2014","unstructured":"Brownell, J. et al. Direct, interferon-independent activation of the CXCL10 promoter by NF-kappaB and interferon regulatory factor 3 during hepatitis C virus infection. J Virol \n                           88, 1582\u20131590, doi:10.1128\/JVI.02007-13 (2014).","journal-title":"J Virol"},{"key":"6784_CR31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ni1243","volume":"6","author":"T Kawai","year":"2005","unstructured":"Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol \n                           6, 981\u2013988, doi:10.1038\/ni1243 (2005).","journal-title":"Nat Immunol"},{"key":"6784_CR32","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1084\/jem.20080091","volume":"205","author":"H Kato","year":"2008","unstructured":"Kato, H. et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med \n                           205, 1601\u20131610, doi:10.1084\/jem.20080091 (2008).","journal-title":"J Exp Med"},{"key":"6784_CR33","doi-asserted-by":"publisher","first-page":"22816","DOI":"10.1074\/jbc.M703019200","volume":"282","author":"D Panne","year":"2007","unstructured":"Panne, D., McWhirter, S. M., Maniatis, T. & Harrison, S. C. Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J Biol Chem \n                           282, 22816\u201322822, doi:10.1074\/jbc.M703019200 (2007).","journal-title":"J Biol Chem"},{"key":"6784_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmb.2008.03.050","volume":"379","author":"W Chen","year":"2008","unstructured":"Chen, W. et al. Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3. J Mol Biol \n                           379, 251\u2013260, doi:10.1016\/j.jmb.2008.03.050 (2008).","journal-title":"J Mol Biol"},{"key":"6784_CR35","doi-asserted-by":"publisher","first-page":"9698","DOI":"10.1074\/jbc.M310616200","volume":"279","author":"M Mori","year":"2004","unstructured":"Mori, M. et al. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J Biol Chem \n                           279, 9698\u20139702, doi:10.1074\/jbc.M310616200 (2004).","journal-title":"J Biol Chem"},{"key":"6784_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jhep.2013.06.001","volume":"59","author":"J Brownell","year":"2013","unstructured":"Brownell, J. et al. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes. J Hepatol \n                           59, 701\u2013708, doi:10.1016\/j.jhep.2013.06.001 (2013).","journal-title":"J Hepatol"},{"key":"6784_CR37","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1126\/science.aaf8325","volume":"353","author":"A Hirai-Yuki","year":"2016","unstructured":"Hirai-Yuki, A. et al. MAVS-dependent host species range and pathogenicity of human hepatitis A virus. Science \n                           353, 1541\u20131545, doi:10.1126\/science.aaf8325 (2016).","journal-title":"Science"},{"key":"6784_CR38","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/hep.24580","volume":"54","author":"S Marukian","year":"2011","unstructured":"Marukian, S. et al. Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology \n                           54, 1913\u20131923, doi:10.1002\/hep.24580 (2011).","journal-title":"Hepatology"},{"key":"6784_CR39","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","volume":"142","author":"E Thomas","year":"2012","unstructured":"Thomas, E. et al. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology \n                           142, 978\u2013988, doi:10.1053\/j.gastro.2011.12.055 (2012).","journal-title":"Gastroenterology"},{"key":"6784_CR40","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/hep.27227","volume":"60","author":"B Israelow","year":"2014","unstructured":"Israelow, B., Narbus, C. M., Sourisseau, M. & Evans, M. J. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection. Hepatology \n                           60, 1170\u20131179, doi:10.1002\/hep.27227 (2014).","journal-title":"Hepatology"},{"key":"6784_CR41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jhep.2010.12.033","volume":"55","author":"M Zeremski","year":"2011","unstructured":"Zeremski, M. et al. Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection. J Hepatol \n                           55, 545\u2013553, doi:10.1016\/j.jhep.2010.12.033 (2011).","journal-title":"J Hepatol"},{"key":"6784_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1365-2893.2006.00838.x","volume":"14","author":"M Zeremski","year":"2007","unstructured":"Zeremski, M., Petrovic, L. M. & Talal, A. H. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat \n                           14, 675\u2013687, doi:10.1111\/j.1365-2893.2006.00838.x (2007).","journal-title":"J Viral Hepat"},{"key":"6784_CR43","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1002\/eji.200425071","volume":"34","author":"MN Ajuebor","year":"2004","unstructured":"Ajuebor, M. N., Hogaboam, C. M., Le, T., Proudfoot, A. E. & Swain, M. G. CCL3\/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol \n                           34, 2907\u20132918, doi:10.1002\/eji.200425071 (2004).","journal-title":"Eur J Immunol"},{"key":"6784_CR44","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0002-9440(10)62060-3","volume":"167","author":"SM Curbishley","year":"2005","unstructured":"Curbishley, S. M., Eksteen, B., Gladue, R. P., Lalor, P. & Adams, D. H. CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol \n                           167, 887\u2013899, doi:10.1016\/S0002-9440(10)62060-3 (2005).","journal-title":"Am J Pathol"},{"key":"6784_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1172\/JCI6642","volume":"104","author":"M Murai","year":"1999","unstructured":"Murai, M. et al. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest \n                           104, 49\u201357, doi:10.1172\/JCI6642 (1999).","journal-title":"J Clin Invest"},{"key":"6784_CR46","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1111\/j.1572-0241.2002.07054.x","volume":"97","author":"A Apolinario","year":"2002","unstructured":"Apolinario, A. et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol \n                           97, 2861\u20132870, doi:10.1111\/j.1572-0241.2002.07054.x (2002).","journal-title":"Am J Gastroenterol"},{"key":"6784_CR47","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1189\/jlb.0303093","volume":"74","author":"CE Harvey","year":"2003","unstructured":"Harvey, C. E. et al. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol \n                           74, 360\u2013369 (2003).","journal-title":"J Leukoc Biol"},{"key":"6784_CR48","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/hep.20167","volume":"39","author":"KJ Helbig","year":"2004","unstructured":"Helbig, K. J. et al. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology \n                           39, 1220\u20131229, doi:10.1002\/hep.20167 (2004).","journal-title":"Hepatology"},{"key":"6784_CR49","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/hep.22500","volume":"48","author":"M Zeremski","year":"2008","unstructured":"Zeremski, M. et al. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology \n                           48, 1440\u20131450, doi:10.1002\/hep.22500 (2008).","journal-title":"Hepatology"},{"key":"6784_CR50","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1006\/viro.1995.1526","volume":"212","author":"H Zhang","year":"1995","unstructured":"Zhang, H. et al. An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect. Virology \n                           212, 686\u2013697 (1995).","journal-title":"Virology"},{"key":"6784_CR51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature12029","volume":"496","author":"Z Feng","year":"2013","unstructured":"Feng, Z. et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature \n                           496, 367\u2013371, doi:10.1038\/nature12029 (2013).","journal-title":"Nature"},{"key":"6784_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-015-2634-5","author":"N Seggewiss","year":"2015","unstructured":"Seggewiss, N., Paulmann, D. & Dotzauer, A. Lysosomes serve as a platform for hepatitis A virus particle maturation and nonlytic release. Arch Virol. doi:10.1007\/s00705-015-2634-5 (2015).","journal-title":"Arch Virol"},{"key":"6784_CR53","doi-asserted-by":"publisher","first-page":"9233","DOI":"10.1128\/JVI.01428-14","volume":"88","author":"PS Sung","year":"2014","unstructured":"Sung, P. S. et al. Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells. J Virol \n                           88, 9233\u20139244, doi:10.1128\/JVI.01428-14 (2014).","journal-title":"J Virol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06784-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06784-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06784-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:17:16Z","timestamp":1671779836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06784-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,25]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6784"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06784-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,25]]},"assertion":[{"value":"23 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6387"}}